Parkinson’s Disease

The Behavioral Neurology of Parkinson’s Disease


Status
Published

Guest Editors

1University of Basel, Basel, Switzerland

2University of Lund, Lund, Sweden

3University of Belgrade, Belgrade, Serbia


The Behavioral Neurology of Parkinson’s Disease

Description

While treating patients with Parkinson’s disease (PD), clinicians are often confronted with complex clinical pictures, involving cognitive and neuropsychiatric changes in addition to the movement disorder. In fact, patients with PD are susceptible to many neurobehavioral and neuropsychiatric conditions such as neuropsychological disturbances, depression, anxiety, apathy, fatigue, and psychosis. While some of them stem from PD-related neuropathological changes, other disturbances may result from dopaminergic medication (e.g., hallucinations and impulse control disorders). Cognitive changes are frequently seen and may range from mild impairment to overt dementia. Psychiatric conditions often accompany or may even precede motor symptoms. Moreover, neurosurgical interventions, such as deep brain stimulation, may also exert undesired symptoms which have to be considered. Finally, since treatment of behavioral alterations in PD can improve patients overall condition and quality of life and may also result in a reduction of caregiver burden, it is important to recognize these alterations timely, in order to treat them decisively.

This special issue is aimed to update and further expand our understanding of the neurobehavioral symptoms encountered in PD by presenting and discussing actual developments in this multifaceted domain.

Potential topics include but are not limited to the following:

  • Epidemiology of neurobehavioral symptoms in PD
  • Anxiety, depression, apathy, fatigue, and psychosis in PD
  • Neuropsychological disturbances in PD
  • MCI and dementia in PD
  • Impulse control disorders and pounding in PD
  • Neuropsychological testing in PD

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 2837685
  • - Clinical Study

Does Dopamine Depletion Trigger a Spreader Lexical-Semantic Activation in Parkinson’s Disease? Evidence from a Study Based on Word Fluency Tasks

S. Zabberoni | G. A. Carlesimo | ... | A. Costa
  • Special Issue
  • - Volume 2017
  • - Article ID 3659784
  • - Research Article

Correlation of Visuospatial Ability and EEG Slowing in Patients with Parkinson’s Disease

Dominique Eichelberger | Pasquale Calabrese | ... | Ute Gschwandtner
  • Special Issue
  • - Volume 2016
  • - Article ID 9869712
  • - Review Article

An Integrated Review of Psychological Stress in Parkinson’s Disease: Biological Mechanisms and Symptom and Health Outcomes

Kim Wieczorek Austin | Suzanne Weil Ameringer | Leslie Jameleh Cloud
  • Special Issue
  • - Volume 2016
  • - Article ID 5380202
  • - Review Article

Mini Review: Anticholinergic Activity as a Behavioral Pathology of Lewy Body Disease and Proposal of the Concept of “Anticholinergic Spectrum Disorders”

Koji Hori | Kimiko Konishi | ... | Mitsugu Hachisu
  • Special Issue
  • - Volume 2016
  • - Article ID 3682936
  • - Research Article

5-HT2A Receptor Binding in the Frontal Cortex of Parkinson’s Disease Patients and Alpha-Synuclein Overexpressing Mice: A Postmortem Study

Nadja Bredo Rasmussen | Mikkel Vestergaard Olesen | ... | Susana Aznar
  • Special Issue
  • - Volume 2016
  • - Article ID 9060649
  • - Review Article

Quantitative EEG and Cognitive Decline in Parkinson’s Disease

Vitalii V. Cozac | Ute Gschwandtner | ... | Peter Fuhr
Parkinson’s Disease
 Journal metrics
Acceptance rate41%
Submission to final decision78 days
Acceptance to publication35 days
CiteScore3.600
Impact Factor1.758
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.